Chlorthalidone in Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT02841280
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT02841280
-
- Other papers using this trial's data
- Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02841280. Randomized; quadruple masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2021-04 (actual). Results posted on 2022-03-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Chlorthalidone in Chronic Kidney Disease
- Acronym
- CLICK
- Condition
- Renal Insufficiency, Chronic
- Condition
- Hypertension
- Intervention (Drug)
- Chlorthalidone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Indiana University
Record details
- Record id
cardio:ct-nct02841280- Content hash
1870715df504bbbc6be87ae76fb52151aa927ae38d4baa1b92a4f8f786df4d10